Europe — EMA

Palonosetron Fresenius Kabi (Palonosetron Hydrochloride)

Palonosetron Hydrochloride, the active ingredient in Palonosetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.

Palonosetron Hydrochloride

Request sourcing

Pack/s

What is Palonosetron Hydrochloride?

Palonosetron Hydrochloride, the active ingredient in Palonosetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Palonosetron Hydrochloride used for?

Palonosetron Fresenius Kabi is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting (CINV): Provides long‑lasting prevention of acute and delayed CINV. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgery. - Radiotherapy‑induced nausea and vomiting: Helps ...

What are the side effects of Palonosetron Hydrochloride?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →